Compare Stocks: INFU, TALK, GMRS, and FLGT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FLGT Fulgent Genetics	$18.66 +0.5%	$19.39	$13.46 ▼ $31.04	$510.68M	0.91	313,485 shs	242,914 shs
GMRS GMR Solutions	$13.83 +3.9%	$13.43	$10.26 ▼ $15.98	$719.03M	N/A	614,997 shs	511,609 shs
INFU InfuSystem	$12.16 -0.9%	$9.92	$7.29 ▼ $12.97	$245.41M	1.42	170,551 shs	94,772 shs
TALK Talkspace	$5.25	$5.21	$2.49 ▼ $5.25	$879.44M	1.1	1.63 million shs	2.41 million shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FLGT Fulgent Genetics	0.00%	-3.03%	-7.94%	+17.10%	-12.70%
GMRS GMR Solutions	0.00%	+5.28%	+0.38%	+1.44%	+1,336,999,900.00%
INFU InfuSystem	0.00%	-1.76%	+37.56%	+37.87%	+27.41%
TALK Talkspace	0.00%	+0.57%	+0.77%	+0.96%	+105.08%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FLGT Fulgent Genetics	$18.66 +0.5%	$19.39	$13.46 ▼ $31.04	$510.68M	0.91	313,485 shs	242,914 shs
GMRS GMR Solutions	$13.83 +3.9%	$13.43	$10.26 ▼ $15.98	$719.03M	N/A	614,997 shs	511,609 shs
INFU InfuSystem	$12.16 -0.9%	$9.92	$7.29 ▼ $12.97	$245.41M	1.42	170,551 shs	94,772 shs
TALK Talkspace	$5.25	$5.21	$2.49 ▼ $5.25	$879.44M	1.1	1.63 million shs	2.41 million shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FLGT Fulgent Genetics	0.00%	-3.03%	-7.94%	+17.10%	-12.70%
GMRS GMR Solutions	0.00%	+5.28%	+0.38%	+1.44%	+1,336,999,900.00%
INFU InfuSystem	0.00%	-1.76%	+37.56%	+37.87%	+27.41%
TALK Talkspace	0.00%	+0.57%	+0.77%	+0.96%	+105.08%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FLGT Fulgent Genetics	2.00	Hold	$27.50	47.37% Upside
GMRS GMR Solutions	2.70	Moderate Buy	$19.22	38.99% Upside
INFU InfuSystem	2.75	Moderate Buy	$16.67	37.06% Upside
TALK Talkspace	2.00	Hold	$5.56	5.95% Upside

Current Analyst Ratings Breakdown

Latest INFU, TALK, GMRS, and FLGT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2026	GMRS GMR Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sell (D)
8/7/2026	TALK Talkspace	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/5/2026	INFU InfuSystem	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$12.00 ➝ $20.00
8/4/2026	FLGT Fulgent Genetics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$15.00 ➝ $19.00
7/6/2026	FLGT Fulgent Genetics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/9/2026	GMRS GMR Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
6/8/2026	GMRS GMR Solutions	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$16.00
6/8/2026	GMRS GMR Solutions	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$18.00
6/8/2026	GMRS GMR Solutions	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Equal Weight	$14.00
6/8/2026	GMRS GMR Solutions	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$20.00
6/8/2026	GMRS GMR Solutions	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$35.00

(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FLGT Fulgent Genetics	$322.67M	1.59	N/A	N/A	$35.80 per share	0.52
GMRS GMR Solutions	N/A	N/A	N/A	N/A	N/A	N/A
INFU InfuSystem	$143.34M	1.71	$0.95 per share	12.79	$2.47 per share	4.92
TALK Talkspace	$228.87M	3.84	$0.06 per share	81.52	$0.71 per share	7.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FLGT Fulgent Genetics	-$60.51M	-$2.82	N/A	N/A	N/A	-26.05%	-4.93%	-4.50%	N/A
GMRS GMR Solutions	N/A	$0.28	49.39	8.18	0.23	N/A	N/A	N/A	N/A
INFU InfuSystem	$870K	$0.41	202.70	39.23	N/A	1.12%	2.78%	1.41%	N/A
TALK Talkspace	$7.79M	N/A	N/A	23.86	N/A	0.08%	0.17%	0.14%	10/29/2026 (Estimated)

Latest INFU, TALK, GMRS, and FLGT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	GMRS GMR Solutions	$0.38	-$1.84	-$2.22	-$1.84	N/A	$1.49 billion
8/6/2026	Q2 2026	TALK Talkspace	$0.0123	-$0.01	-$0.0223	-$0.01	$67.99 million	$61.67 million
7/30/2026	Q2 2026	FLGT Fulgent Genetics	-$0.46	-$0.58	-$0.12	-$1.05	$94.00 million	$85.39 million
6/1/2026	Q1 2026	GMRS GMR Solutions	N/A	$0.28	N/A	$0.28	N/A	$1.46 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FLGT Fulgent Genetics	N/A	N/A	N/A	N/A	N/A
GMRS GMR Solutions	N/A	N/A	N/A	N/A	N/A
INFU InfuSystem	N/A	N/A	N/A	N/A	N/A
TALK Talkspace	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FLGT Fulgent Genetics	N/A	6.34	6.34
GMRS GMR Solutions	5.50	2.01	2.01
INFU InfuSystem	0.50	1.98	1.59
TALK Talkspace	N/A	4.52	4.52

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FLGT Fulgent Genetics	48.06%
GMRS GMR Solutions	N/A
INFU InfuSystem	71.13%
TALK Talkspace	57.37%

Insider Ownership

Company	Insider Ownership
FLGT Fulgent Genetics	36.18%
GMRS GMR Solutions	N/A
INFU InfuSystem	10.80%
TALK Talkspace	23.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FLGT Fulgent Genetics	1,315	27.51 million	17.56 million	Optionable
GMRS GMR Solutions	N/A	54.02 million	N/A	N/A
INFU InfuSystem	410	20.18 million	19.10 million	Optionable
TALK Talkspace	500	167.51 million	128.15 million	Optionable

INFU, TALK, GMRS, and FLGT Headlines

Recent News About These Companies

UHS closes $835M Talkspace acquisition, creating end-to-end behavioral health continuum

August 17 at 1:46 PM | beckershospitalreview.comB

Universal Health Services, Inc. Completes Acquisition of Talkspace, Inc.

August 17 at 1:46 PM | tmcnet.com

Universal Health Services closes $835M Talkspace acquisition

August 17 at 8:45 AM | fiercehealthcare.comF

‘A game changer’: UHS closes $835M Talkspace acquisition

August 17 at 8:45 AM | finance.yahoo.com

Talkspace, Inc. (NASDAQ:TALK) Given Consensus Rating of "Hold" by Analysts

August 17 at 3:29 AM | americanbankingnews.com

Talkspace (NASDAQ:TALK) Reaches New 12-Month High - Still a Buy?

August 12, 2026 | marketbeat.com

Talkspace, Inc. (NASDAQ:TALK) Receives Average Rating of "Hold" from Brokerages

August 12, 2026 | marketbeat.com

Talkspace (NASDAQ:TALK): What Could Today’s Update Reveal About Virtual Care Engagement And Payer Demand?

August 10, 2026 | kalkinemedia.comK

'Raising the standard': Inside Talkspace's bold new AI mental health support tool

August 10, 2026 | msn.com

Janus Henderson Group PLC Invests $1.55 Million in Talkspace, Inc. $TALK

August 10, 2026 | marketbeat.com

Dimensional Fund Advisors LP Raises Stake in Talkspace, Inc. $TALK

August 9, 2026 | marketbeat.com

Talkspace (NASDAQ:TALK) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS

August 8, 2026 | marketbeat.com

Talkspace (NASDAQ:TALK) Sees Unusually-High Trading Volume - What's Next?

August 7, 2026 | marketbeat.com

652,800 Shares in Talkspace, Inc. $TALK Acquired by Groupe la Francaise

August 1, 2026 | marketbeat.com

Renaissance Technologies LLC Purchases 523,400 Shares of Talkspace, Inc. $TALK

August 1, 2026 | marketbeat.com

Arrowstreet Capital Limited Partnership Raises Holdings in Talkspace, Inc. $TALK

July 31, 2026 | marketbeat.com

529,410 Shares in Talkspace, Inc. $TALK Acquired by Gabelli Funds LLC

July 29, 2026 | marketbeat.com

Talkspace (TALK) to Release Quarterly Earnings on Tuesday

July 28, 2026 | marketbeat.com

Polar Asset Management Partners Inc. Purchases Shares of 3,002,132 Talkspace, Inc. $TALK

July 27, 2026 | marketbeat.com

329,151 Shares in Talkspace, Inc. $TALK Acquired by Hsbc Holdings PLC

July 27, 2026 | marketbeat.com

Punch & Associates Investment Management Inc. Takes $2.33 Million Position in Talkspace, Inc. $TALK

July 26, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

INFU, TALK, GMRS, and FLGT Company Descriptions

Fulgent Genetics NASDAQ:FLGT

$18.66 +0.10 (+0.54%)

As of 04:00 PM Eastern

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

GMR Solutions NYSE:GMRS

$13.83 +0.52 (+3.91%)

As of 03:58 PM Eastern

GMR Solutions Inc. is a provider of emergency medical services delivering EMS and other essential out-of-hospital care in rural and urban communities. GMR Solutions Inc. is based in Lewisville, Texas.

InfuSystem NYSE:INFU

$12.16 -0.11 (-0.90%)

As of 04:00 PM Eastern

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Talkspace NASDAQ:TALK

$5.25 0.00 (0.00%)

Closing price 08/14/2026 07:34 PM Eastern

Extended Trading

$5.25 0.00 (0.00%)

As of 08/14/2026 07:34 PM Eastern

Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest INFU, TALK, GMRS, and FLGT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest INFU, TALK, GMRS, and FLGT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

INFU, TALK, GMRS, and FLGT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

INFU, TALK, GMRS, and FLGT Company Descriptions

Fulgent Genetics NASDAQ:FLGT

GMR Solutions NYSE:GMRS

InfuSystem NYSE:INFU

Talkspace NASDAQ:TALK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest INFU, TALK, GMRS, and FLGT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest INFU, TALK, GMRS, and FLGT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

INFU, TALK, GMRS, and FLGT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

INFU, TALK, GMRS, and FLGT Company Descriptions

Fulgent Genetics NASDAQ:FLGT

GMR Solutions NYSE:GMRS

InfuSystem NYSE:INFU

Talkspace NASDAQ:TALK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools